Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Patients Who

- PMLiVE

Nurturing change in pharma marketing

Multichannel pharma marketing could be ready to hatch

Daiichi Sankyo logo

Daiichi Sankyo pays $39m in whistleblower case

Accused of paying US doctors to prescribe its drugs

- PMLiVE

Novartis forms digital health investment company with Qualcomm

Expands work with Tricorder prize firm to develop 'beyond-the-pill' initiatives

23andMe signs Parkinson’s deal with Genentech

Adds to list of pharma tie-ups for genetic testing firm

Daiichi Sankyo logo

Daiichi’s novel anticoagulant Savaysa cleared in US

Approval comes more than three years after it was approved in Japan

US doctors support digital health technology

Mobile devices and apps find favour in new survey

- PMLiVE

Hackers target deal-rich pharma sector

Look to gain access to insider information for stock market gain

23andMe launches personal genome service in the UK

Mail-order genetic service will cost £125

- PMLiVE

UCB partners with Daiichi to bring epilepsy drug to Japan

Companies partner on expanding market for Vimpat

- PMLiVE

Life sciences minister: Go digital for NHS savings

Greater use of health technology could free funds for drug spending, says George Freeman

UK unveils digital health strategy

Plans greater use of mobile technology and will track NHS 'digital health maturity'

Novo taps behavioural change for diabetes programme’s re-launch

Adds health coach function to Cornerstones4Care

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links